Transperineal ultrasound guided I-125/Pd-103 brachytherapy for early stage prostate cancer: Update on clinical experience at seven years

被引：4
|
作者：
Grimm, PD
Blasko, J
Ragde, H
Sylvester, J
Cavanagh, W
机构：
[1] SWEDISH MED CTR,NW PROSTATE INST,SEATTLE,WA
[2] UNIV WASHINGTON,MED CTR,DEPT RADIAT ONCOL,SEATTLE,WA 98195
[3] NORTHWEST HOSP,SEATTLE,WA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 39卷 / 02期
关键词：
D O I：
10.1016/S0360-3016(97)80726-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [11] Dosimetric Comparison of Permanent Prostate Brachytherapy Plans Utilizing Cs-131, I-125 and Pd-103 Seeds
    Yang, R.
    Wang, J.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [12] ANISOTROPY FUNCTIONS FOR PD-103, I-125, AND IR-192 INTERSTITIAL BRACHYTHERAPY SOURCES
    NATH, R
    MEIGOONI, AS
    MUENCH, P
    MELILLO, A
    MEDICAL PHYSICS, 1993, 20 (05) : 1465 - 1473
  • [13] Is Cs-131 or I-125 or Pd-103 the "Ideal" isotope for prostate boost brachytherapy? A dosimetric view point
    Yaparpalvi, R.
    Rossinow, J.
    Cavanagh, W. A.
    Choi, W.
    Minsky, L.
    Kahan, N.
    Bodner, W.
    Garg, M.
    Kalnicki, S.
    Guha, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S677 - S678
  • [14] Empirical scaling laws for determination of activities and numbers of I-125 and Pd-103 sources in ultrasound based prostate implants
    Zhang, H
    Menyhart, G
    Meigonni, AS
    RADIOLOGY, 2002, 225 : 193 - 193
  • [15] Permanent implantation of the prostate with Pd-103 and J 125 seeds -: 5 years of experience
    Oismüller, R
    Somay, C
    Ponholzer, A
    Büchler, F
    Hawliczek, R
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S40 - S41
  • [16] A biomathematical model for calculating the dose delivered by I-125 or Pd-103 seeds to the edematous prostate
    Yue, N
    Waterman, FM
    Corn, BW
    Dicker, AP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 345 - 345
  • [17] Dosimetric analysis of urinary morbidity following prostate brachytherapy (I-125 vs Pd-103) combined with external beam radiation therapy
    Chen, CT
    Waterman, FM
    Dicker, AP
    RADIOLOGY, 2000, 217 : 214 - 214
  • [18] Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study
    Tang, Chad
    Sanders, Jeremiah
    Thames, Howard
    Swanson, David M.
    Crook, Juanita M.
    Bruno, Teresa
    Blanchard, Pierre
    Ciezki, Jay
    Keyes, Mira
    Song, Daniel
    Singh, Tanmay
    Merrick, Gregory
    Stock, Richard
    Sullivan, Francis J.
    Mok, Henry
    Millar, Jeremy
    Frank, Steven J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 183
  • [19] Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103
    DePaoli, B.
    McVorran, S. M.
    Case, M. J.
    Khaleghi, S.
    Li, H.
    Marshall, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E218 - E218
  • [20] Interstitial Brachytherapy of the prostate with Pd-103 and Jod-125, toxicity comparison and results after 8 years
    Oismueller, R.
    Somay, C.
    Poljanc, K.
    Futschek, B.
    Futschek, T.
    Ponholzer, A.
    Hawliczek, R.
    Maderbacher, S.
    Rauchenwald, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 171 - 172
12345